US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Teva Pharmaceutical

18.07

+0.30001.69%

Post-market: 18.080.0100+0.06%19:58 EDT

Volume:9.05M

Turnover:162.86M

Market Cap:20.73B

PE:-15.81

High:18.09

Open:17.90

Low:17.78

Close:17.77

Loading ...

Overview Company News Filings

Teva Delivers Second Consecutive Year of Growth; Announces Strong Financial Results in Fourth Quarter and Full Year 2024, Led by Generics Performance and Innovative Portfolio Growth

Calendar of U.S. Earnings Expected in the Week Ahead

Teva Pharmaceutical Industries Ltd expected to post earnings of 70 cents a share - Earnings Preview

Alvotech, Teva Filing for Inflammatory Treatment Candidate Accepted for FDA Review

MT Newswires Live

Alvotech, Teva announce FDA accepts BLA for AVT05

Alvotech Sa - FDA Review Process Expected to Complete in Q4 2025

THOMSON REUTERS

Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Applications for Avt05, a Proposed Biosimilar to Simponi® and Simponi Aria® (Golimumab)

THOMSON REUTERS

Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Applications for AVT05, a Proposed Biosimilar to Simponi® and Simponi Aria® (golimumab)

FDA adds boxed warning to Teva’s Copaxone for allergic reaction

Ozempic, Xtandi among next 15 drugs selected for U.S. price talks

Popular Ozempic, Wegovy Selected For Next Round Of Medicare Drug Price Negotiations

Novo Nordisk's stock down 4% as the Feds get ready for a second round of drug price negotiations

Teva price target raised to $30 from $23 at Piper Sandler

Teva Pharmaceutical (TEVA) Receives a Buy from Piper Sandler

Barclays Remains a Buy on Teva Pharmaceutical (TEVA)

Humira Holds Firm at 72% Market Share--AbbVie Fends Off Biosimilar Surge

Samsung Bioepis Partners with Teva Pharmaceutical for Blood Disease Drug Biosimilar EPYSQLI in the US

MT Newswires Live

Amicus Posts Preliminary 2024 Results, Issues 2025 Outlook

Teva Pharmaceutical’s Growth Potential and Strategic Market Positioning

Teva Pharmaceuticals International Enters Collaboration to Commercialize Eye Disease Treatment

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/TEVA/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TEVA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TEVA\",,,,,undefined,":{"symbol":"TEVA","market":"US","secType":"STK","nameCN":"Teva Pharmaceutical","latestPrice":18.07,"timestamp":1749499200000,"preClose":17.77,"halted":0,"volume":9052872,"hourTrading":{"tag":"盘后","latestPrice":18.08,"preClose":18.07,"latestTime":"19:58 EDT","volume":488498,"amount":8827215.3856,"timestamp":1749513519938},"delay":0,"floatShares":1141343536,"shares":1146959855,"eps":-1.142604,"marketStatus":"Not Yet Opened","change":0.3,"latestTime":"06-09 16:00:00 EDT","open":17.9,"high":18.09,"low":17.775,"amount":162859492.49868,"amplitude":0.017727,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.142604,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1749542400000},"marketStatusCode":0,"adr":0,"adrRate":1,"exchange":"NYSE","adjPreClose":17.77,"dividendRate":0.000055,"preHourTrading":{"tag":"盘前","latestPrice":17.92,"preClose":17.77,"latestTime":"09:29 EDT","volume":18698,"amount":337808.127524,"timestamp":1749475741366},"postHourTrading":{"tag":"盘后","latestPrice":18.08,"preClose":18.07,"latestTime":"19:58 EDT","volume":488498,"amount":8827215.3856,"timestamp":1749513519938},"volumeRatio":0.847987,"optionData":{"bulkOrders":[{"symbol":"TEVA","call":true,"expireDate":1750392000000,"strike":"15.0","timestamp":1749481210572,"price":2.95,"volume":6665,"amount":1966175,"type":"-"},{"symbol":"TEVA","call":false,"expireDate":1750392000000,"strike":"15.0","timestamp":1749481210572,"price":0.07,"volume":6665,"amount":46655,"type":"-"}]},"impliedVol":0.3701,"impliedVolPercentile":0.068},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TEVA\",,,,,undefined,":{"symbol":"TEVA","floatShares":1141343536,"roa":"5.27%","roe":"-19.11%","lyrEps":-1.44916,"volumeRatio":0.847987,"shares":1146959855,"dividePrice":0.001,"high":18.09,"amplitude":0.017727,"preClose":17.77,"low":17.775,"week52Low":12.465,"pbRate":"3.31","psRate":"1.25","week52High":22.8,"institutionHeld":0.6547,"latestPrice":18.07,"eps":-1.142604,"divideRate":0.000055,"volume":9052872,"delay":0,"ttmEps":-1.142604,"open":17.9,"prevYearClose":22.04,"prevWeekClose":17.77,"prevMonthClose":16.78,"prevQuarterClose":15.37,"fiveDayClose":17.26,"twentyDayClose":16.93,"sixtyDayClose":16.46},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TEVA\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2507687830","title":"Teva Delivers Second Consecutive Year of Growth; Announces Strong Financial Results in Fourth Quarter and Full Year 2024, Led by Generics Performance and Innovative Portfolio Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2507687830","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507687830?lang=en_us&edition=fundamental","pubTime":"2025-01-29 20:00","pubTimestamp":1738152000,"startTime":"0","endTime":"0","summary":"2024 Revenues of $16.5 billion reflect an increase of 6%, in local currency terms, compared to 2023;AUSTEDO - exceeding $1.6 billion in revenues, surpassing 2024 outlook;AJOVY - global annual revenues of $507 million, an increase of 18% in local currency terms compared to 2023;UZEDY revenues of $117 million in 2024 surpassing $100M outlook;Generics business continues to grow across all segments, with increases of 15% in the U.S., 6% in Europe and 15% in International Markets, all in local currency terms compared to 2023;First-to-market launches including first generic version of Sandostatin LAR Depot and liraglutide injection 1.8mg ; On January 2025, Teva entered into a license and supply agreement, for a proposed generic GLP1 in the U.S., Europe and additional countries;Biosimilar pipeline is expanding, and now includes 18 assets, including SELARSDITM, which is expected to launch in the U.S. in the first quarter of 2025; and our first internally developed biosimilar to Prolia , which ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/teva-delivers-second-consecutive-growth-120000340.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4535","API","BK4596","TEVA","BK4559","BK4585","BK4007","BK4503","BK4023","BK4551","BK4566","BK4588","BK4584","BK4557"],"gpt_icon":0},{"id":"2507681896","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2507681896","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507681896?lang=en_us&edition=fundamental","pubTime":"2025-01-29 19:00","pubTimestamp":1738148400,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Applied Indus Tech                               2Q      2.21    6:30 AM. ·ASML Hldg NV                                    4Q      7.04    1:00 AM. ·C.H. Robnsn Wrldwd                              4Q      1.11    4:05 PM. ·Cndn Pacf Kansas City                             4Q       .86        AMC. ·CGI Inc. Class A                                 1Q      1.39    6:30 AM. ·Eagle Materials Inc.                             3Q      3.91    6:30 AM. ·Grp 1 Automotive                                 4Q      9.11    5:01 AM. ·Intl Bus Machines Corp                           4Q      3.78    4:08 PM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CI","AJG","CVCO","AMP","TEAM","TEVA","FLWS","WOLF","MTH","NOW","AMSC","ALGM","AIT","EAT","WM","MSFT","MSCI","MXL","GPI","URI","WDC","NAVI","CRS","CSWI","LRCX","TER","WASH","DHR","SMFG","BKR","TSLA","SMG","LSTR","GLW","SLGN","GD","CHRW","AOS","LII","CIVB","TTEK","RHI","TMUS","SIGI","FLEX","LEVI","APPF","CFR"],"gpt_icon":1},{"id":"2506376563","title":"Teva Pharmaceutical Industries Ltd  expected to post earnings of 70 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2506376563","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506376563?lang=en_us&edition=fundamental","pubTime":"2025-01-27 20:05","pubTimestamp":1737979506,"startTime":"0","endTime":"0","summary":"Teva Pharmaceutical Industries Ltd  expected to post earnings of70cents a share - Earnings Preview Teva Pharmaceutical Industries Ltd TEVA.N, TEVA.K is expected to show a fall in quarterly revenue whe","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250127:nL5N3ON0TO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEVA"],"gpt_icon":0},{"id":"2506037506","title":"Alvotech, Teva Filing for Inflammatory Treatment Candidate Accepted for FDA Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2506037506","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506037506?lang=en_us&edition=fundamental","pubTime":"2025-01-27 20:02","pubTimestamp":1737979329,"startTime":"0","endTime":"0","summary":"Alvotech  and Teva Pharmaceutical  said Monday that the US Food and Drug Administration has accepted to review their biologics license applications for AVT05 to treat inflammatory conditions.The review process is expected to be completed in Q4.This comes after the achievement of positive top-line results in April 2024 from a confirmatory clinical study comparing AVT05 with biosimilar Simponi in patients with rheumatoid arthritis.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4584","BK4007","BK4566","BK4139","BK4557","TEVA","BK4596","BK4588","BK4559","ALVO"],"gpt_icon":0},{"id":"2506378427","title":"Alvotech, Teva announce FDA accepts BLA for AVT05","url":"https://stock-news.laohu8.com/highlight/detail?id=2506378427","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506378427?lang=en_us&edition=fundamental","pubTime":"2025-01-27 19:11","pubTimestamp":1737976267,"startTime":"0","endTime":"0","summary":"Alvotech (ALVO) and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), announced that the U.S. FDA has accepted ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alvotech-teva-announce-fda-accepts-bla-for-avt05?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alvotech-teva-announce-fda-accepts-bla-for-avt05?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4596","BK4566","BK4559","BK4588","BK4007","BK4139","BK4557","TEVA","BK4584","BK4585","ALVO"],"gpt_icon":0},{"id":"2506204443","title":"Alvotech Sa - FDA Review Process Expected to Complete in Q4 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2506204443","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506204443?lang=en_us&edition=fundamental","pubTime":"2025-01-27 19:00","pubTimestamp":1737975601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250127:nTUA1KMCKB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TEVA","BK4596","BK4559","BK4585","BK4139","BK4007","BK4566","BK4588","BK4584","BK4557","ALVO"],"gpt_icon":0},{"id":"2506416320","title":"Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Applications for Avt05, a Proposed Biosimilar to Simponi® and Simponi Aria® (Golimumab)","url":"https://stock-news.laohu8.com/highlight/detail?id=2506416320","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506416320?lang=en_us&edition=fundamental","pubTime":"2025-01-27 19:00","pubTimestamp":1737975600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250127:nTUA202GZW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TEVA","BK4588","BK4596","BK4566","BK4559","BK4139","BK4585","BK4557","ALVO","BK4584","BK4007"],"gpt_icon":0},{"id":"2506202813","title":"Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Applications for AVT05, a Proposed Biosimilar to Simponi® and Simponi Aria® (golimumab)","url":"https://stock-news.laohu8.com/highlight/detail?id=2506202813","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506202813?lang=en_us&edition=fundamental","pubTime":"2025-01-27 19:00","pubTimestamp":1737975600,"startTime":"0","endTime":"0","summary":"REYKJAVIK, Iceland and PARSIPPANY, N.J., Jan. 27, 2025  -- Alvotech , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. , today announced that the U.S. Food and Drug Administration  has accepted for review Biologics License Applications  for AVT05, Alvotech’s proposed biosimilar to Simponi and Simponi Aria , which are prescribed to treat a variety of inflammatory conditions. These are the first U.S. BLA filing acceptances announced for a biosimilar candidate to golimumab. The FDA review process for these applications is anticipated to be completed in the fourth quarter of 2025.\"This is a significant step towards being able to offer U.S. patients access to biosimilar golimumab,\" said Joseph McClellan, Chief Scientific Officer of Alvotech. “Our in-house capability allowing us to match the cell line and process used to manufacture the ref","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/alvotech-teva-announce-filing-acceptance-110000366.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","BK4224","BK4555","F","FR","BK4574","BK4171","BK4585","BK4099","BK4139","TEVA","BK4156","ALVO","BK4516","ALVOW"],"gpt_icon":0},{"id":"2505013778","title":"FDA adds boxed warning to Teva’s Copaxone for allergic reaction","url":"https://stock-news.laohu8.com/highlight/detail?id=2505013778","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505013778?lang=en_us&edition=fundamental","pubTime":"2025-01-23 00:25","pubTimestamp":1737563135,"startTime":"0","endTime":"0","summary":"The Food and Drug Administration is adding a boxed warning about the risk of an allergic reaction for Teva‘s (TEVA) Copaxone and Sandoz’s (SDZNY) G...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fda-adds-boxed-warning-to-tevas-copaxone-for-allergic-reaction?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fda-adds-boxed-warning-to-tevas-copaxone-for-allergic-reaction?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4584","BK4566","BK4007","BK4557","TEVA","BK4596","SDZNY","BK4588","BK4559"],"gpt_icon":0},{"id":"2504010332","title":"Ozempic, Xtandi among next 15 drugs selected for U.S. price talks","url":"https://stock-news.laohu8.com/highlight/detail?id=2504010332","media":"TipRanks","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504010332?lang=en_us&edition=fundamental","pubTime":"2025-01-18 21:20","pubTimestamp":1737206448,"startTime":"0","endTime":"0","summary":"The Department of Health and Human Services, through the Centers for Medicare & Medicaid Services, announced the selection of 15 additional drugs covered under Medicare Part D for price negotiations. In accordance with the Inflation Reduction Act, the negotiations with participating drug companies for these 15 drugs will occur in 2025 and any negotiated prices will become effective in 2027, the agency said in a statement. The selected drug list for the second cycle of negotiations is: Novo Nordisk’s  Ozempic, Rybelsus, and Wegovy, GSK‘s  Trelegy Ellipta, Pfizer’s  Xtandi, Bristol Myers’  Pomalyst, Pfizer’s  Ibrance, Boehringer Ingleheim’s Ofev, AbbVie  and Ironwood’s  Linzess, AstraZeneca’s  Calquence, Teva‘s  Austedo, GSK and Theravance’s  Breo Ellipta, Boehringer’s Tradjenta, Salix’s  Xifaxan, AbbVie’s Vraylar, Merck’s  Janumet, and Amgen’s  Otezla. Companies with a selected drug will have until February 28 to decide if they will participate in negotiations.Discover outperforming sto","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/ozempic-xtandi-among-next-15-132048211.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ozempic-xtandi-among-next-15-132048211.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2237443622.USD","TEVA","ABBV","IE00B3PB1722.GBP","LU0029864427.USD","IE00B19Z3B42.SGD","MRK","LU0256863902.USD","LU2236285917.USD","LU1941712348.USD","NVO","LU0306807586.USD","SG9999002232.USD","IE00BVYPNV92.GBP","AZN","LU1571399168.USD","IE00B42XCP33.USD","LU0256863811.USD","LU0320765489.SGD","LU1699723380.USD","GSK.UK","LU0417517546.SGD","PFE","TBPH","BK4581","LU1323610961.USD","LU2023250843.SGD","LU1003077747.HKD","SG9999001440.SGD","LU2468319806.SGD","BHC","LU0234570918.USD","BMY","AMGN","LU2361045086.USD","SG9999014575.USD","LU2417539215.USD","LU1037948541.HKD","GSK","LU2462157665.USD","SG9999015952.SGD","LU1989771016.USD","SGXZ57979304.SGD","SG9999003800.SGD","LU0109394709.USD","LU2461242641.AUD","LU2023250504.SGD","IE00BDGV0183.EUR","IRWD","IE00B2B36J28.USD"],"gpt_icon":1},{"id":"2504949981","title":"Popular Ozempic, Wegovy Selected For Next Round Of Medicare Drug Price Negotiations","url":"https://stock-news.laohu8.com/highlight/detail?id=2504949981","media":"Benzinga","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504949981?lang=en_us&edition=fundamental","pubTime":"2025-01-18 01:15","pubTimestamp":1737134120,"startTime":"0","endTime":"0","summary":"On Friday, the U.S. Department of Health and Human Services  unveiled the selection of 15 additional drugs covered under Medicare Part D for price negotiations, building on efforts to reduce prescription drug costs.These negotiations, mandated by the Inflation Reduction Act, will take place in 2025, with the new prices slated to take effect in 2027.The selected drugs, used to treat conditions like cancer, diabetes, and asthma, represented approximately $41 billion in Medicare Part D costs between November 2023 and October 2024, accounting for 14% of the program's total expenses.Under the finalized guidance for the second negotiation cycle, drug manufacturers have until February 28, 2025, to decide on their participation.The selected drug list for the second cycle of negotiations is:. Novo Nordisk'sdiabetes and weight loss drugs, Ozempic, Rybelsus, and Wegovy.Pfizer Inc.'s  Ibrance for breast cancer and Xtandi for prostate cancer.GSK Plc's  Asthma and Chronic obstructive pulmonary disea","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/popular-ozempic-wegovy-selected-next-171520498.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BJT1NW94.SGD","AZN","BPOP","SG9999015986.USD","BK4533","TEVA","IE00BKVL7J92.USD","LU0912757837.SGD","BMY","LU0943347566.SGD","LU0211331839.USD","BK4550","LU2468319806.SGD","IE00BDGV0183.EUR","LU1868836757.USD","LU0949170772.SGD","MRK","HHS","LU0208291251.USD","BK4592","IE00BLSP4452.SGD","SG9999014559.SGD","LU1934455194.USD","BK4599","BK4568","LU0256863811.USD","SG9999015978.USD","LU1037948541.HKD","ABBV","AMGN","LU1585245621.USD","LU2106854487.HKD","LU2237443895.HKD","LU1868837136.USD","GSK","LU0965509010.AUD","LU1116320737.USD","LU1934455863.HKD","LU0321505868.SGD","LU1894683264.USD","LU2242646821.SGD","PFE","LU1989772840.SGD","LU1074936037.SGD","LU2456880835.USD","LU0820561818.USD","GSK.UK","LU0820561909.HKD","LU1989771016.USD","NVO"],"gpt_icon":1},{"id":"2504416479","title":"Novo Nordisk's stock down 4% as the Feds get ready for a second round of drug price negotiations","url":"https://stock-news.laohu8.com/highlight/detail?id=2504416479","media":"Yahoo Finance","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504416479?lang=en_us&edition=fundamental","pubTime":"2025-01-17 22:46","pubTimestamp":1737125184,"startTime":"0","endTime":"0","summary":"The Centers for Medicare and Medicaid Services  released its second round of drug negotiation targets, a list of 15 drugs under Medicare Part D, including Novo Nordisk's  blockbuster GLP-1s.Novo was trading down 4% on the news Friday.Diabetes drug Ozempic and weight loss drug Wegovy top the list, along with a number of others like Merck's  diabetes drug Janumet.Ozempic, Wegovy, Rybelsus: Novo Nordisk diabetes and obesity drugs. \"If there's something that can help Americans stay healthy, we want to take a look at that. These new drugs are going to be part of the consideration the next administration goes through,\" Becerra said.Novo's semaglutide drugs on the new list comes as no surprise, as speculations were rampant about their inclusion in recent months. But it could also shift the market dynamics and impact Eli Lilly's competitive portfolio with no reign on pricing for its tirzepatide drugs — Mounjaro for diabetes and Zepbound for weight loss.Novo Nordisk currently has 55% of the GLP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/novo-nordisks-stock-down-4-as-the-feds-get-ready-for-a-second-round-of-drug-price-negotiations-144624687.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2462157665.USD","LU1894683264.USD","LU0211327993.USD","LU2023251221.USD","LU0795875086.SGD","LU1585245621.USD","LU0708994859.HKD","PFE","MRK","IE00B19Z3B42.SGD","LU2346227817.USD","IE00B42XCP33.USD","SG9999001176.SGD","LU0912757837.SGD","LU0070302665.USD","LU1074936037.SGD","IE00BBT3K403.USD","LU0122379950.USD","CMS","LU1917777945.USD","AZN","LU1116320901.HKD","TEVA","HHS","LU1003077747.HKD","LU0456855351.SGD","LU1066051498.USD","LU1974910355.USD","GSK","LU1323610961.USD","GSK.UK","LU0225284248.USD","LU1670710661.SGD","LU1699723380.USD","IE000M9KFDE8.USD","BMY","LU0553294199.USD","ABBV","IE00B1BXHZ80.USD","LU0306807586.USD","LU0265550359.USD","LU1868836757.USD","LU1883839398.USD","IE00B19Z3581.USD","IE00B3PB1722.GBP","SG9999015945.SGD","LU0795875169.SGD","NVO","LU0965509283.SGD","BK4139"],"gpt_icon":1},{"id":"2504715467","title":"Teva price target raised to $30 from $23 at Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2504715467","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504715467?lang=en_us&edition=fundamental","pubTime":"2025-01-17 20:15","pubTimestamp":1737116150,"startTime":"0","endTime":"0","summary":"Piper Sandler raised the firm’s price target on Teva (TEVA) to $30 from $23 and keeps an Overweight rating on the shares after meeting with managem...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/teva-price-target-raised-to-30-from-23-at-piper-sandler?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/teva-price-target-raised-to-30-from-23-at-piper-sandler?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4596","BK4559","TEVA","BK4557","BK4588","BK4584","BK4566","BK4007","BK4585"],"gpt_icon":0},{"id":"2504159166","title":"Teva Pharmaceutical (TEVA) Receives a Buy from Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2504159166","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504159166?lang=en_us&edition=fundamental","pubTime":"2025-01-17 19:45","pubTimestamp":1737114357,"startTime":"0","endTime":"0","summary":"In a report released today, David Amsellem from Piper Sandler reiterated a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with a price...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/teva-pharmaceutical-teva-receives-a-buy-from-piper-sandler-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/teva-pharmaceutical-teva-receives-a-buy-from-piper-sandler-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4584","BK4566","BK4007","BK4557","TEVA","BK4596","BK4588","BK4559"],"gpt_icon":0},{"id":"2504139692","title":"Barclays Remains a Buy on Teva Pharmaceutical (TEVA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2504139692","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504139692?lang=en_us&edition=fundamental","pubTime":"2025-01-17 17:36","pubTimestamp":1737106573,"startTime":"0","endTime":"0","summary":"In a report released today, Balaji Prasad from Barclays maintained a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with a price targe...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/barclays-remains-a-buy-on-teva-pharmaceutical-teva-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/barclays-remains-a-buy-on-teva-pharmaceutical-teva-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4584","BK4557","BK4585","BK4596","TEVA","BK4007","BK4559","BK4588","BK4566"],"gpt_icon":0},{"id":"2504917291","title":"Humira Holds Firm at 72% Market Share--AbbVie Fends Off Biosimilar Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=2504917291","media":"GuruFocus.com","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504917291?lang=en_us&edition=fundamental","pubTime":"2025-01-17 00:41","pubTimestamp":1737045694,"startTime":"0","endTime":"0","summary":"AbbVie  is ticking up; according to a new Samsung Bioepis report, Humira's U.S. market share stays above 70% even with increasing biosimilar competition.Losing U.S. exclusivity in early 2023, Humira, the top-selling arthritis medication from AbbVie, let biosimilars from Amgen , Teva , and Pfizer  onto the market. After factoring over a third of AbbVie's income in 2022, Humira's share fell to 27% in 2023.GuruFocus has detected 5 Warning Signs with ABBV.Humira still dominated 96% of the market as of February 2024, but its share dropped to 77% in May after several pharmacy benefit managers, notably CVS Health , kicked it off important formularies.AbbVie has 72% of the adalimumab market as of November 2024; biosimilars are taking center stage, rising from 2% to 23% in a year. Humira is still the leading market participant even with the evolving rivalry.This article first appeared on","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/humira-holds-firm-72-market-164134395.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1244550577.SGD","LU0306806265.USD","SG9999003800.SGD","LU1093756168.USD","IE00BVYPNW00.USD","IE00B3PB1722.GBP","IE00BVYPNV92.GBP","BK4566","ABBV","LU0456855351.SGD","BK4196","TEVA","LU0006061336.USD","LU1839511570.USD","IE00BKVL7J92.USD","LU0820561909.HKD","LU0058720904.USD","LU0203347892.USD","LU1037948541.HKD","IE00BJT1NW94.SGD","LU1496350502.SGD","SG9999015945.SGD","LU0211327993.USD","LU0889565916.HKD","CVS","LU0738911758.USD","LU0965509283.SGD","LU1883839398.USD","LU1003077747.HKD","LU1989772923.USD","LU1496350171.SGD","LU2237443622.USD","LU2089283258.USD","AMGN","LU0158827948.USD","LU1061106388.HKD","LU1066053197.SGD","BK4568","LU0882574055.USD","LU0029864427.USD","IE00BZ1G4Q59.USD","BK4599","PFE","LU1934455277.USD","LU0256863902.USD","IE00BDGV0183.EUR","IE00B2B36J28.USD","LU1244550221.USD","BK4581","IE0004445239.USD"],"gpt_icon":1},{"id":"2503595566","title":"Samsung Bioepis Partners with Teva Pharmaceutical for Blood Disease Drug Biosimilar EPYSQLI in the US","url":"https://stock-news.laohu8.com/highlight/detail?id=2503595566","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503595566?lang=en_us&edition=fundamental","pubTime":"2025-01-14 11:33","pubTimestamp":1736825630,"startTime":"0","endTime":"0","summary":"Samsung Biologics (KRX:207940) subsidiary Samsung Bioepis and Israel's Teva Pharmaceutical entered into a licensing, development, and commercialization agreement for EPYSQLI, or eculizumab-aagh, biosi","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4596","BK4559","TEVA","BK4557","BK4588","BK4584","BK4566","BK4007","BK4585"],"gpt_icon":0},{"id":"2503391055","title":"Amicus Posts Preliminary 2024 Results, Issues 2025 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2503391055","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503391055?lang=en_us&edition=fundamental","pubTime":"2025-01-14 00:31","pubTimestamp":1736785860,"startTime":"0","endTime":"0","summary":"Amicus Therapeutics FOLD announced preliminary total revenues for the fourth quarter and full-year 2024. The company’s top line currently comprises sales of the lead product, Galafold , which is approved for treating Fabry disease and Pombiliti + Opfolda.The FDA approved Pombiliti + Opfolda, a two-component therapy for treating late-onset Pompe disease, in September 2023.Along with the preliminary results, Amicus also outlined key strategic priorities and outlook for 2025.In the past year, shares of Amicus have plunged 31.6% compared with the industry’s decline of 16%.For full-year 2025, management expects total revenues to grow in the range of 17%-24% on a constant exchange rate .Revenues from Galafold are expected to grow in the range of 10%-15% at CER in 2025.Both Fabry disease and Pompe disease are rare diseases. Amicus is currently advancing ongoing studies to broaden labels in Fabry and Pompe diseases.Amicus expects to achieve positive GAAP net income in the second half of 2025. ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/amicus-posts-preliminary-2024-results-163100240.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["FOLD","BK4196","BK4588","TEVA","LU2065170008.USD","BK4559","BK4007","LU2065171311.SGD","CSTL","BK4557","BK4584","BK4139","CTMX","LU2065171402.SGD","BK4585","BK4596","BK4566","LU2065169927.USD"],"gpt_icon":0},{"id":"2503049370","title":"Teva Pharmaceutical’s Growth Potential and Strategic Market Positioning","url":"https://stock-news.laohu8.com/highlight/detail?id=2503049370","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503049370?lang=en_us&edition=fundamental","pubTime":"2025-01-13 19:46","pubTimestamp":1736768799,"startTime":"0","endTime":"0","summary":"Analyst Jason Gerberry from Bank of America Securities reiterated a Buy rating on Teva Pharmaceutical (TEVA – Research Report) and increased the pr...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/teva-pharmaceuticals-growth-potential-and-strategic-market-positioning?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/teva-pharmaceuticals-growth-potential-and-strategic-market-positioning?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0002270589.USD","LU1366192091.USD","LU1074936037.SGD","IE00B19Z3581.USD","BK4566","LU0477156797.USD","LU1880398471.USD","LU0640476718.USD","TEVA","LU2129689431.USD","LU2133065610.SGD","LU0130103400.USD","LU0106831901.USD","LU0208291251.USD","BK4557","LU0256863811.USD","LU0070302665.USD","LU1883839398.USD","IE00BLSP4452.SGD","LU0234572021.USD","LU1280957306.USD","LU1791807156.HKD","LU0130518102.USD","LU1201861165.SGD","BK4559","LU1894683348.USD","BK4585","LU0053666078.USD","LU0256863902.USD","IE00BBT3K403.USD","LU2129689605.HKD","BAC","LU0321505868.SGD","BK4584","BK4553","LU0417517546.SGD","LU1267930227.SGD","LU1894683264.USD","BK4504","LU0980610538.SGD","IE00B7SZLL34.SGD","LU1496350171.SGD","LU0320765646.SGD","IE00B19Z3B42.SGD","LU0868494617.USD","IE00BFXG1179.USD","LU0170899867.USD","BK4581","IE00BZ1G4Q59.USD","LU0128525689.USD"],"gpt_icon":0},{"id":"2503373131","title":"Teva Pharmaceuticals International Enters Collaboration to Commercialize Eye Disease Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2503373131","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503373131?lang=en_us&edition=fundamental","pubTime":"2025-01-13 17:32","pubTimestamp":1736760768,"startTime":"0","endTime":"0","summary":"Teva Pharmaceutical Industries'  Teva Pharmaceuticals International subsidiary said Monday it has entered into a collaboration with Klinge Biopharma and Formycon for the semi-exclusive commercialization of FYB203, Formycon's biosimilar candidate to Eylea, in Israel and Europe, excluding Italy.Financial terms were not disclosed.Klinge has licensed the exclusive global commercialization rights for FYB203, intended to treat eye diseases, from Formycon, the company said.Under the terms of the collaboration, Teva will lead the commercialization of FYB203 in designated regions under the brand name Ahzantive, while Klinge will receive milestone payments and a portion of product revenue, the company said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4566","BK4557","BK4588","BK4584","BK4596","TEVA","BK4585","BK4559","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TEVA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-07","symbol":"TEVA","fiscalQuarterEnding":"2025/03","expectedEps":0.47,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746590400000,"reportTimeType":"pre","actualEps":0.49},{"market":"US","date":"2025-01-29","symbol":"TEVA","fiscalQuarterEnding":"2024/12","expectedEps":0.66,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1738126800000,"reportTimeType":"pre","actualEps":0.7},{"market":"US","date":"2024-11-06","symbol":"TEVA","fiscalQuarterEnding":"2024/09","expectedEps":0.63,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730869200000,"reportTimeType":"pre","actualEps":0.67},{"market":"US","date":"2024-07-31","symbol":"TEVA","fiscalQuarterEnding":"2024/06","expectedEps":0.55,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1722398400000,"reportTimeType":"pre","actualEps":0.58},{"market":"US","date":"2024-05-08","symbol":"TEVA","fiscalQuarterEnding":"2024/03","expectedEps":0.49,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715140800000,"reportTimeType":"pre","actualEps":0.46}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TEVA\",market:\"US\",,,undefined,":[{"executeDate":"2015-08-18","recordDate":"2015-08-20","paymentDate":"2015-09-03","value":0.289,"currency":"USD"},{"executeDate":"2015-11-13","recordDate":"2015-11-17","paymentDate":"2015-12-03","value":0.289,"currency":"USD"},{"executeDate":"2016-02-25","recordDate":"2016-02-29","paymentDate":"2016-03-14","value":0.289,"currency":"USD"},{"executeDate":"2016-05-20","recordDate":"2016-05-24","paymentDate":"2016-06-07","value":0.289,"currency":"USD"},{"executeDate":"2016-08-18","recordDate":"2016-08-22","paymentDate":"2016-09-08","value":0.289,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TEVA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2727,"buy":0.5455,"hold":0.0909,"sell":0.0909,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5455,"analysts":11,"updateTime":1749441600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TEVA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TEVA","date":"2025-06-06","current":-15.384959,"percent":0.228128,"low":-47.420609,"twenty":-16.419614,"median":-5.284921,"eighty":-2.637593,"high":3468.133499,"avg":130.705964,"sd":595.655924,"marketCap":19785057498},"quantilePoints":[{"date":"2020-06-12","current":-14.938974,"twenty":-2.691669,"median":7.55798,"eighty":19.246698,"marketCap":12324653741},{"date":"2020-06-19","current":-16.824605,"twenty":-2.723388,"median":6.839112,"eighty":19.224557,"marketCap":13880298924},{"date":"2020-06-26","current":-16.187209,"twenty":-2.746903,"median":6.605128,"eighty":19.137656,"marketCap":13354447031},{"date":"2020-07-02","current":-15.071765,"twenty":-2.770437,"median":-1.045636,"eighty":19.099162,"marketCap":12434206218},{"date":"2020-07-10","current":-15.616208,"twenty":-2.790652,"median":-1.062517,"eighty":19.081439,"marketCap":12883371377},{"date":"2020-07-17","current":-16.412953,"twenty":-2.805417,"median":-1.079484,"eighty":19.030594,"marketCap":13540686243},{"date":"2020-07-24","current":-15.257672,"twenty":-2.827292,"median":-1.105759,"eighty":18.98189,"marketCap":12587579687},{"date":"2020-07-31","current":-15.324068,"twenty":-2.849167,"median":-1.116081,"eighty":18.936119,"marketCap":12642355926},{"date":"2020-08-07","current":3268.239835,"twenty":-2.855117,"median":-1.118783,"eighty":18.907339,"marketCap":13072959341},{"date":"2020-08-14","current":3150.35627,"twenty":-2.855117,"median":-1.118783,"eighty":18.907339,"marketCap":12601425081},{"date":"2020-08-21","current":2709.306392,"twenty":-2.855117,"median":-1.118783,"eighty":18.907339,"marketCap":10837225569},{"date":"2020-08-28","current":2629.862625,"twenty":-2.855117,"median":-1.118783,"eighty":18.907339,"marketCap":10519450502},{"date":"2020-09-04","current":2517.545576,"twenty":-2.855117,"median":-1.118783,"eighty":18.907339,"marketCap":10070182303},{"date":"2020-09-11","current":2407.967966,"twenty":-2.855117,"median":-1.118783,"eighty":18.907339,"marketCap":9631871866},{"date":"2020-09-18","current":2596.989343,"twenty":-2.855117,"median":-1.118783,"eighty":18.907339,"marketCap":10387957371},{"date":"2020-09-25","current":2388.791885,"twenty":-2.855117,"median":-1.118783,"eighty":18.907339,"marketCap":9555167539},{"date":"2020-10-02","current":2470.975092,"twenty":-2.855117,"median":-1.118783,"eighty":18.94668,"marketCap":9883900367},{"date":"2020-10-09","current":2692.869751,"twenty":-2.855117,"median":-1.118783,"eighty":18.94668,"marketCap":10771479004},{"date":"2020-10-16","current":2577.813261,"twenty":-2.855117,"median":-1.118783,"eighty":18.94668,"marketCap":10311253044},{"date":"2020-10-23","current":2561.376619,"twenty":-2.855117,"median":-1.118783,"eighty":18.960483,"marketCap":10245506478},{"date":"2020-10-30","current":2388.791885,"twenty":-2.855117,"median":-1.118783,"eighty":18.970629,"marketCap":9555167539},{"date":"2020-11-06","current":-2.479598,"twenty":-2.855117,"median":-1.122535,"eighty":18.977532,"marketCap":9995260590},{"date":"2020-11-13","current":-2.580196,"twenty":-2.855117,"median":-1.13285,"eighty":18.977532,"marketCap":10400770066},{"date":"2020-11-20","current":-2.577477,"twenty":-2.855117,"median":-1.159421,"eighty":18.970629,"marketCap":10389810350},{"date":"2020-11-27","current":-2.669918,"twenty":-2.855117,"median":-1.167378,"eighty":18.907339,"marketCap":10762440679},{"date":"2020-12-04","current":-2.794986,"twenty":-2.855117,"median":-1.19662,"eighty":18.876363,"marketCap":11266587595},{"date":"2020-12-11","current":-2.80858,"twenty":-2.868879,"median":-1.206311,"eighty":18.831741,"marketCap":11321386173},{"date":"2020-12-18","current":-2.721577,"twenty":-2.868879,"median":-1.218948,"eighty":18.767819,"marketCap":10970675275},{"date":"2020-12-24","current":-2.672637,"twenty":-2.868879,"median":-1.245853,"eighty":18.713856,"marketCap":10773400395},{"date":"2020-12-31","current":-2.623698,"twenty":-2.868879,"median":-1.254451,"eighty":18.705041,"marketCap":10576125515},{"date":"2021-01-08","current":-2.933648,"twenty":-2.890141,"median":-1.330328,"eighty":18.653693,"marketCap":11825533089},{"date":"2021-01-15","current":-3.251754,"twenty":-2.93694,"median":-1.36644,"eighty":18.618565,"marketCap":13107819809},{"date":"2021-01-22","current":-3.412166,"twenty":-2.970208,"median":-1.391911,"eighty":18.571548,"marketCap":13754443027},{"date":"2021-01-29","current":-3.202814,"twenty":-3.004914,"median":-1.411761,"eighty":18.521647,"marketCap":12910544929},{"date":"2021-02-05","current":-3.327882,"twenty":-3.040774,"median":-1.489022,"eighty":18.485499,"marketCap":13414691845},{"date":"2021-02-12","current":-3.055943,"twenty":-3.075085,"median":-1.495472,"eighty":18.465291,"marketCap":12193211794},{"date":"2021-02-19","current":-3.033958,"twenty":-3.084796,"median":-1.519016,"eighty":18.419652,"marketCap":12105490846},{"date":"2021-02-26","current":-2.957009,"twenty":-3.090354,"median":-1.528691,"eighty":18.381903,"marketCap":11798467527},{"date":"2021-03-05","current":-2.891054,"twenty":-3.092207,"median":-1.533851,"eighty":18.348285,"marketCap":11535304683},{"date":"2021-03-12","current":-2.965254,"twenty":-3.094346,"median":-1.548687,"eighty":18.29633,"marketCap":11831362883},{"date":"2021-03-19","current":-3.165869,"twenty":-3.107046,"median":-1.557072,"eighty":18.276086,"marketCap":12631816535},{"date":"2021-03-26","current":-3.182358,"twenty":-3.123547,"median":-1.569004,"eighty":18.273427,"marketCap":12697607246},{"date":"2021-04-01","current":-3.154876,"twenty":-3.132058,"median":-1.587972,"eighty":18.270767,"marketCap":12587956060},{"date":"2021-04-09","current":-3.033958,"twenty":-3.14019,"median":-1.643277,"eighty":18.240014,"marketCap":12105490846},{"date":"2021-04-16","current":-2.954261,"twenty":-3.14019,"median":-1.74145,"eighty":18.209845,"marketCap":11787502409},{"date":"2021-04-23","current":-2.829086,"twenty":-3.14019,"median":-1.782486,"eighty":18.152512,"marketCap":11288054497},{"date":"2021-04-30","current":-2.962113,"twenty":-3.140098,"median":-1.805963,"eighty":18.125512,"marketCap":11795135070},{"date":"2021-05-07","current":-2.864508,"twenty":-3.140098,"median":-1.838334,"eighty":18.125512,"marketCap":11406472230},{"date":"2021-05-14","current":-2.911332,"twenty":-3.140098,"median":-1.872266,"eighty":18.125512,"marketCap":11592924180},{"date":"2021-05-21","current":-3.035277,"twenty":-3.140098,"median":-1.892281,"eighty":18.125512,"marketCap":12086473459},{"date":"2021-05-28","current":-2.864508,"twenty":-3.140098,"median":-1.900028,"eighty":18.125512,"marketCap":11406472230},{"date":"2021-06-04","current":-2.864508,"twenty":-3.140098,"median":-1.934046,"eighty":18.123394,"marketCap":11406472230},{"date":"2021-06-11","current":-3.060066,"twenty":-3.140793,"median":-1.942725,"eighty":18.095231,"marketCap":12185183315},{"date":"2021-06-18","current":-2.787387,"twenty":-3.140793,"median":-1.955715,"eighty":18.095231,"marketCap":11099374901},{"date":"2021-06-25","current":-2.853491,"twenty":-3.140793,"median":-1.962405,"eighty":18.095231,"marketCap":11362601183},{"date":"2021-07-02","current":-2.707511,"twenty":-3.140793,"median":-1.971497,"eighty":18.095231,"marketCap":10781309810},{"date":"2021-07-09","current":-2.561532,"twenty":-3.140793,"median":-1.979274,"eighty":18.095231,"marketCap":10200018436},{"date":"2021-07-16","current":-2.371482,"twenty":-3.140793,"median":-1.99345,"eighty":18.065112,"marketCap":9443242875},{"date":"2021-07-23","current":-2.426569,"twenty":-3.140793,"median":-2.00987,"eighty":18.020915,"marketCap":9662598110},{"date":"2021-07-30","current":-2.718479,"twenty":-3.140793,"median":-2.02672,"eighty":17.936008,"marketCap":10642846609},{"date":"2021-08-06","current":-2.819894,"twenty":-3.140793,"median":-2.047324,"eighty":17.86933,"marketCap":11039885446},{"date":"2021-08-13","current":-2.769187,"twenty":-3.140793,"median":-2.064068,"eighty":17.7757,"marketCap":10841366027},{"date":"2021-08-20","current":-2.574808,"twenty":-3.140793,"median":-2.081189,"eighty":17.662044,"marketCap":10080374923},{"date":"2021-08-27","current":-2.633967,"twenty":-3.140793,"median":-2.096758,"eighty":17.589353,"marketCap":10311980911},{"date":"2021-09-03","current":-2.670589,"twenty":-3.140793,"median":-2.136235,"eighty":17.521986,"marketCap":10455356047},{"date":"2021-09-10","current":-2.588894,"twenty":-3.140793,"median":-2.157064,"eighty":17.392,"marketCap":10135519206},{"date":"2021-09-17","current":-2.532552,"twenty":-3.140793,"median":-2.16522,"eighty":17.258426,"marketCap":9914942074},{"date":"2021-09-24","current":-2.521284,"twenty":-3.140793,"median":-2.180608,"eighty":17.140589,"marketCap":9870826648},{"date":"2021-10-01","current":-2.732565,"twenty":-3.140793,"median":-2.190178,"eighty":16.863606,"marketCap":10697990892},{"date":"2021-10-08","current":-2.86215,"twenty":-3.140623,"median":-2.212175,"eighty":16.581714,"marketCap":11205318295},{"date":"2021-10-15","current":-2.726931,"twenty":-3.140623,"median":-2.224813,"eighty":16.430857,"marketCap":10675933179},{"date":"2021-10-22","current":-2.853699,"twenty":-3.140623,"median":-2.234816,"eighty":16.203499,"marketCap":11172231725},{"date":"2021-10-29","current":13.278626,"twenty":-3.140623,"median":-2.237038,"eighty":15.915254,"marketCap":9640282648},{"date":"2021-11-05","current":13.871151,"twenty":-3.140623,"median":-2.237038,"eighty":14.703723,"marketCap":10070455443},{"date":"2021-11-12","current":14.448482,"twenty":-3.140623,"median":-2.237038,"eighty":14.141585,"marketCap":10489598167},{"date":"2021-11-19","current":13.491327,"twenty":-3.140623,"median":-2.237038,"eighty":14.007714,"marketCap":9794703651},{"date":"2021-11-26","current":12.898803,"twenty":-3.140623,"median":-2.237038,"eighty":13.603755,"marketCap":9364530856},{"date":"2021-12-03","current":12.230314,"twenty":-3.140623,"median":-2.237038,"eighty":13.26951,"marketCap":8879207702},{"date":"2021-12-10","current":12.670909,"twenty":-3.140623,"median":-2.237038,"eighty":12.871456,"marketCap":9199079781},{"date":"2021-12-17","current":12.458208,"twenty":-3.140623,"median":-2.237038,"eighty":12.652866,"marketCap":9044658777},{"date":"2021-12-23","current":12.853224,"twenty":-3.140623,"median":-2.237038,"eighty":12.613301,"marketCap":9331440641},{"date":"2021-12-31","current":12.169542,"twenty":-3.140623,"median":-2.237038,"eighty":12.5674,"marketCap":8835087415},{"date":"2022-01-07","current":13.445749,"twenty":-3.140452,"median":-2.236529,"eighty":12.5827,"marketCap":9761613436},{"date":"2022-01-14","current":13.931922,"twenty":-3.140452,"median":-2.236529,"eighty":12.5827,"marketCap":10114575730},{"date":"2022-01-21","current":12.929189,"twenty":-3.140452,"median":-2.236529,"eighty":12.5827,"marketCap":9386590999},{"date":"2022-01-28","current":12.670909,"twenty":-3.140452,"median":-2.236529,"eighty":12.56332,"marketCap":9199079781},{"date":"2022-02-04","current":12.929189,"twenty":-3.140452,"median":-2.236529,"eighty":12.56332,"marketCap":9386590999},{"date":"2022-02-11","current":22.56931,"twenty":-3.140452,"median":-2.236529,"eighty":12.56332,"marketCap":9411402306},{"date":"2022-02-18","current":21.563878,"twenty":-3.140452,"median":-2.236529,"eighty":12.56332,"marketCap":8992137022},{"date":"2022-02-25","current":22.119511,"twenty":-3.140452,"median":-2.236529,"eighty":12.56332,"marketCap":9223836258},{"date":"2022-03-04","current":19.738224,"twenty":-3.140452,"median":-2.236529,"eighty":12.56332,"marketCap":8230839532},{"date":"2022-03-11","current":19.791142,"twenty":-3.140452,"median":-2.236529,"eighty":12.56332,"marketCap":8252906126},{"date":"2022-03-18","current":21.008826,"twenty":-3.140452,"median":-2.236529,"eighty":12.56332,"marketCap":8760680412},{"date":"2022-03-25","current":22.952608,"twenty":-3.140452,"median":-2.236529,"eighty":12.56332,"marketCap":9571237662},{"date":"2022-04-01","current":25.002899,"twenty":-3.140452,"median":-2.236529,"eighty":12.56332,"marketCap":10426209007},{"date":"2022-04-08","current":27.692242,"twenty":-3.140452,"median":-2.236529,"eighty":12.56332,"marketCap":11547664928},{"date":"2022-04-14","current":27.133072,"twenty":-3.140452,"median":-2.236529,"eighty":12.56332,"marketCap":11314490925},{"date":"2022-04-22","current":24.283966,"twenty":-3.140452,"median":-2.236529,"eighty":12.56332,"marketCap":10126413860},{"date":"2022-04-29","current":23.192253,"twenty":-3.140452,"median":-2.236529,"eighty":12.56332,"marketCap":9671169377},{"date":"2022-05-06","current":-14.154736,"twenty":-3.172242,"median":-2.25283,"eighty":12.488311,"marketCap":8705162792},{"date":"2022-05-13","current":-14.0103,"twenty":-3.205318,"median":-2.260954,"eighty":12.429626,"marketCap":8616334600},{"date":"2022-05-20","current":-15.29217,"twenty":-3.276345,"median":-2.281282,"eighty":12.245781,"marketCap":9404684802},{"date":"2022-05-27","current":-16.321278,"twenty":-3.31569,"median":-2.291347,"eighty":11.985489,"marketCap":10037585668},{"date":"2022-06-03","current":-16.790695,"twenty":-3.328426,"median":-2.29948,"eighty":11.789502,"marketCap":10326277292},{"date":"2022-06-10","current":-15.021353,"twenty":-3.371392,"median":-2.314197,"eighty":11.688865,"marketCap":9238131943},{"date":"2022-06-17","current":-13.920028,"twenty":-3.408869,"median":-2.342978,"eighty":11.639906,"marketCap":8560816980},{"date":"2022-06-24","current":-13.974191,"twenty":-3.452748,"median":-2.356224,"eighty":11.348874,"marketCap":8594127552},{"date":"2022-07-01","current":-14.245009,"twenty":-3.539192,"median":-2.386785,"eighty":10.834809,"marketCap":8760680412},{"date":"2022-07-08","current":-13.432556,"twenty":-3.647481,"median":-2.418306,"eighty":10.77515,"marketCap":8261021833},{"date":"2022-07-15","current":-12.656212,"twenty":-3.692345,"median":-2.440647,"eighty":10.695627,"marketCap":7783570302},{"date":"2022-07-22","current":-12.656212,"twenty":-3.733536,"median":-2.456867,"eighty":10.545138,"marketCap":7783570302},{"date":"2022-07-29","current":-9.883393,"twenty":-3.783945,"median":-2.463627,"eighty":10.456545,"marketCap":10417096473},{"date":"2022-08-05","current":-11.263697,"twenty":-3.859125,"median":-2.480033,"eighty":10.139869,"marketCap":11871936172},{"date":"2022-08-12","current":-11.811603,"twenty":-4.662476,"median":-2.488236,"eighty":9.908676,"marketCap":12449429793},{"date":"2022-08-19","current":-10.926523,"twenty":-4.855781,"median":-2.509199,"eighty":9.496608,"marketCap":11516555482},{"date":"2022-08-26","current":-10.104663,"twenty":-7.328779,"median":-2.526918,"eighty":9.235909,"marketCap":10650315051},{"date":"2022-09-02","current":-9.314413,"twenty":-7.460438,"median":-2.534518,"eighty":8.539587,"marketCap":9817391559},{"date":"2022-09-09","current":-9.662123,"twenty":-7.588383,"median":-2.544228,"eighty":8.396377,"marketCap":10183877895},{"date":"2022-09-16","current":-9.282803,"twenty":-7.708389,"median":-2.560413,"eighty":7.75588,"marketCap":9784074619},{"date":"2022-09-23","current":-8.323967,"twenty":-7.837841,"median":-2.564286,"eighty":7.146957,"marketCap":8773460782},{"date":"2022-09-30","current":-8.50309,"twenty":-7.954693,"median":-2.577477,"eighty":6.631627,"marketCap":8962256773},{"date":"2022-10-07","current":-8.91402,"twenty":-8.041279,"median":-2.589545,"eighty":1.906977,"marketCap":9395376989},{"date":"2022-10-14","current":-8.37665,"twenty":-8.108759,"median":-2.602979,"eighty":-1.058703,"marketCap":8828989015},{"date":"2022-10-21","current":-8.892947,"twenty":-8.254205,"median":-2.612933,"eighty":-1.077333,"marketCap":9373165696},{"date":"2022-10-28","current":-9.38817,"twenty":-8.370996,"median":-2.61826,"eighty":-1.103341,"marketCap":9895131084},{"date":"2022-11-04","current":-7.286725,"twenty":-8.4182,"median":-2.627686,"eighty":-1.11572,"marketCap":9407161532},{"date":"2022-11-11","current":-8.155626,"twenty":-8.4182,"median":-2.640011,"eighty":-1.122973,"marketCap":10528912789},{"date":"2022-11-18","current":-7.501799,"twenty":-8.4182,"median":-2.646916,"eighty":-1.133601,"marketCap":9684822734},{"date":"2022-11-25","current":-7.630844,"twenty":-8.4182,"median":-2.652295,"eighty":-1.154623,"marketCap":9851419455},{"date":"2022-12-02","current":-7.450181,"twenty":-8.4182,"median":-2.657764,"eighty":-1.167975,"marketCap":9618184045},{"date":"2022-12-09","current":-7.260916,"twenty":-8.4182,"median":-2.667232,"eighty":-1.196871,"marketCap":9373842187},{"date":"2022-12-16","current":-7.47599,"twenty":-8.4182,"median":-2.670589,"eighty":-1.206624,"marketCap":9651503390},{"date":"2022-12-23","current":-7.949154,"twenty":-8.4182,"median":-2.679639,"eighty":-1.218984,"marketCap":10262358035},{"date":"2022-12-30","current":-7.845918,"twenty":-8.4182,"median":-2.685107,"eighty":-1.245981,"marketCap":10129080658},{"date":"2023-01-06","current":-9.050336,"twenty":-8.490335,"median":-2.685107,"eighty":-1.245981,"marketCap":11683983390},{"date":"2023-01-13","current":-9.66975,"twenty":-8.513614,"median":-2.685107,"eighty":-1.245981,"marketCap":12483647653},{"date":"2023-01-20","current":-8.955703,"twenty":-8.55512,"median":-2.685107,"eighty":-1.245981,"marketCap":11561812461},{"date":"2023-01-27","current":-8.929894,"twenty":-8.616931,"median":-2.685107,"eighty":-1.245981,"marketCap":11528493117},{"date":"2023-02-03","current":-9.256807,"twenty":-8.658116,"median":-2.685107,"eighty":-1.245981,"marketCap":11950538144},{"date":"2023-02-10","current":-4.843957,"twenty":-8.665667,"median":-2.696044,"eighty":-1.249887,"marketCap":11397831773},{"date":"2023-02-17","current":-4.749533,"twenty":-8.665667,"median":-2.710028,"eighty":-1.287834,"marketCap":11175651816},{"date":"2023-02-24","current":-4.678715,"twenty":-8.665667,"median":-2.721577,"eighty":-1.357669,"marketCap":11009016849},{"date":"2023-03-03","current":-4.740091,"twenty":-8.665667,"median":-2.726931,"eighty":-1.387204,"marketCap":11153433821},{"date":"2023-03-10","current":-4.30574,"twenty":-8.665667,"median":-2.735171,"eighty":-1.40268,"marketCap":10131406020},{"date":"2023-03-17","current":-3.946928,"twenty":-8.665667,"median":-2.743833,"eighty":-1.47613,"marketCap":9287122185},{"date":"2023-03-24","current":-3.984698,"twenty":-8.665667,"median":-2.762598,"eighty":-1.494118,"marketCap":9375994168},{"date":"2023-03-31","current":-4.178267,"twenty":-8.663663,"median":-2.769529,"eighty":-1.502762,"marketCap":9831463079},{"date":"2023-04-06","current":-4.34351,"twenty":-8.663663,"median":-2.77623,"eighty":-1.523472,"marketCap":10220278003},{"date":"2023-04-14","current":-4.371837,"twenty":-8.665667,"median":-2.787387,"eighty":-1.5314,"marketCap":10286931990},{"date":"2023-04-21","current":-3.975941,"twenty":-8.665667,"median":-2.794986,"eighty":-1.543656,"marketCap":9355388563},{"date":"2023-04-28","current":-4.056888,"twenty":-8.665667,"median":-2.80155,"eighty":-1.553815,"marketCap":9545857552},{"date":"2023-05-05","current":-4.128312,"twenty":-8.665667,"median":-2.808152,"eighty":-1.565328,"marketCap":9713918424},{"date":"2023-05-12","current":-5.734745,"twenty":-8.66767,"median":-2.811371,"eighty":-1.580115,"marketCap":9198531749},{"date":"2023-05-19","current":-5.769671,"twenty":-8.66767,"median":-2.815669,"eighty":-1.600505,"marketCap":9254552040},{"date":"2023-05-26","current":-5.123253,"twenty":-8.66767,"median":-2.823193,"eighty":-1.733806,"marketCap":8212574631},{"date":"2023-06-02","current":-5.03239,"twenty":-8.66767,"median":-2.827292,"eighty":-1.759051,"marketCap":8066921875},{"date":"2023-06-09","current":-5.16519,"twenty":-8.66767,"median":-2.83303,"eighty":-1.79258,"marketCap":8279798980},{"date":"2023-06-16","current":-5.297989,"twenty":-8.66767,"median":-2.842331,"eighty":-1.834111,"marketCap":8492676085},{"date":"2023-06-23","current":-5.277021,"twenty":-8.669674,"median":-2.850882,"eighty":-1.8531,"marketCap":8459063910},{"date":"2023-06-30","current":-5.290999,"twenty":-8.685793,"median":-2.853491,"eighty":-1.884437,"marketCap":8481472027},{"date":"2023-07-07","current":-5.472725,"twenty":-8.699909,"median":-2.856943,"eighty":-1.893935,"marketCap":8772777539},{"date":"2023-07-14","current":-5.661439,"twenty":-8.714024,"median":-2.86215,"eighty":-1.904829,"marketCap":9075287109},{"date":"2023-07-21","current":-5.920048,"twenty":-8.714024,"median":-2.865002,"eighty":-1.93738,"marketCap":9489837261},{"date":"2023-07-28","current":-5.885101,"twenty":-8.714024,"median":-2.873833,"eighty":-1.952158,"marketCap":9433816970},{"date":"2023-08-04","current":-4.800636,"twenty":-8.72814,"median":-2.888799,"eighty":-1.955074,"marketCap":10724621897},{"date":"2023-08-11","current":-4.840767,"twenty":-8.72814,"median":-2.904838,"eighty":-1.955074,"marketCap":10814273908},{"date":"2023-08-18","current":-4.770538,"twenty":-8.72814,"median":-2.911332,"eighty":-1.955074,"marketCap":10657382888},{"date":"2023-08-25","current":-4.8508,"twenty":-8.72814,"median":-2.931253,"eighty":-1.955074,"marketCap":10836686911},{"date":"2023-09-01","current":-4.895947,"twenty":-8.72814,"median":-2.939134,"eighty":-1.955074,"marketCap":10937545424},{"date":"2023-09-08","current":-4.690277,"twenty":-8.72814,"median":-2.954829,"eighty":-1.955074,"marketCap":10478078865},{"date":"2023-09-14","current":-5.181878,"twenty":-8.72814,"median":-2.957009,"eighty":-1.955074,"marketCap":11576316008},{"date":"2023-09-22","current":-5.186895,"twenty":-8.742256,"median":-2.966419,"eighty":-1.954647,"marketCap":11587522509},{"date":"2023-09-29","current":-5.126699,"twenty":-8.742256,"median":-2.976841,"eighty":-1.954512,"marketCap":11453044492},{"date":"2023-10-06","current":-4.685261,"twenty":-8.742256,"median":-2.992075,"eighty":-1.954512,"marketCap":10466872363},{"date":"2023-10-13","current":-4.479591,"twenty":-8.742256,"median":-3.004047,"eighty":-1.954512,"marketCap":10007405803},{"date":"2023-10-20","current":-4.093333,"twenty":-8.742256,"median":-3.015213,"eighty":-1.954377,"marketCap":9144505191},{"date":"2023-10-27","current":-4.148512,"twenty":-8.742256,"median":-3.027087,"eighty":-1.953971,"marketCap":9267776707},{"date":"2023-11-03","current":-4.404346,"twenty":-8.742256,"median":-3.039408,"eighty":-1.953971,"marketCap":9839308281},{"date":"2023-11-10","current":-4.449118,"twenty":-8.742256,"median":-3.054185,"eighty":-1.953971,"marketCap":9828101780},{"date":"2023-11-17","current":-4.445318,"twenty":-8.742256,"median":-3.083177,"eighty":-1.953971,"marketCap":9819707729},{"date":"2023-11-24","current":-4.846209,"twenty":-8.742256,"median":-3.094417,"eighty":-1.953971,"marketCap":10705274979},{"date":"2023-12-01","current":-4.983222,"twenty":-8.742256,"median":-3.11228,"eighty":-1.953971,"marketCap":11007937203},{"date":"2023-12-08","current":-5.05934,"twenty":-8.742256,"median":-3.121898,"eighty":-1.957883,"marketCap":11176082883},{"date":"2023-12-15","current":-5.191279,"twenty":-8.742256,"median":-3.140281,"eighty":-1.964182,"marketCap":11467535396},{"date":"2023-12-22","current":-5.373963,"twenty":-8.742256,"median":-3.175748,"eighty":-1.973937,"marketCap":11871085029},{"date":"2023-12-29","current":-5.313069,"twenty":-8.742256,"median":-3.194657,"eighty":-1.979923,"marketCap":11736568484},{"date":"2024-01-05","current":-5.521126,"twenty":-8.744895,"median":-3.254473,"eighty":-1.994731,"marketCap":12196166677},{"date":"2024-01-12","current":-5.785003,"twenty":-8.747534,"median":-3.303065,"eighty":-2.020282,"marketCap":12779071702},{"date":"2024-01-19","current":-5.576946,"twenty":-8.750172,"median":-3.324939,"eighty":-2.086994,"marketCap":12319473509},{"date":"2024-01-26","current":-6.003209,"twenty":-8.747534,"median":-3.350993,"eighty":-2.113662,"marketCap":13261089319},{"date":"2024-02-02","current":-24.986228,"twenty":-8.792334,"median":-3.394528,"eighty":-2.231182,"marketCap":13967301176},{"date":"2024-02-09","current":-24.244261,"twenty":-8.880303,"median":-3.546059,"eighty":-2.28208,"marketCap":13552541832},{"date":"2024-02-16","current":-26.473061,"twenty":-8.902871,"median":-3.699813,"eighty":-2.289098,"marketCap":14798440945},{"date":"2024-02-23","current":-26.169858,"twenty":-8.923739,"median":-3.699813,"eighty":-2.289098,"marketCap":14628950780},{"date":"2024-03-01","current":-26.370394,"twenty":-9.053777,"median":-3.70305,"eighty":-2.290222,"marketCap":14741050020},{"date":"2024-03-08","current":-27.493391,"twenty":-9.139505,"median":-3.70305,"eighty":-2.290222,"marketCap":15368805762},{"date":"2024-03-15","current":-27.072267,"twenty":-9.210651,"median":-3.70305,"eighty":-2.290222,"marketCap":15133397359},{"date":"2024-03-22","current":-27.573605,"twenty":-9.283565,"median":-3.70305,"eighty":-2.290222,"marketCap":15413645458},{"date":"2024-03-28","current":-28.937246,"twenty":-9.314413,"median":-3.70305,"eighty":-2.290222,"marketCap":16175920288},{"date":"2024-04-05","current":-27.934569,"twenty":-9.368646,"median":-3.699813,"eighty":-2.289098,"marketCap":15615424090},{"date":"2024-04-12","current":-27.814248,"twenty":-9.433738,"median":-3.699813,"eighty":-2.289098,"marketCap":15548164546},{"date":"2024-04-19","current":-25.894717,"twenty":-9.525147,"median":-3.699813,"eighty":-2.289098,"marketCap":14475146829},{"date":"2024-04-26","current":-26.847027,"twenty":-9.663648,"median":-3.70305,"eighty":-2.290222,"marketCap":15007487910},{"date":"2024-05-03","current":-28.528765,"twenty":-9.858133,"median":-3.70305,"eighty":-2.290222,"marketCap":15947579605},{"date":"2024-05-10","current":-37.912656,"twenty":-10.011941,"median":-3.70305,"eighty":-2.290222,"marketCap":18122249552},{"date":"2024-05-17","current":-38.623518,"twenty":-10.428566,"median":-3.735419,"eighty":-2.290222,"marketCap":18462041731},{"date":"2024-05-24","current":-39.713507,"twenty":-10.612531,"median":-3.918801,"eighty":-2.290222,"marketCap":18983056405},{"date":"2024-05-31","current":-40.043539,"twenty":-10.762386,"median":-3.985619,"eighty":-2.290222,"marketCap":19140811509},{"date":"2024-06-07","current":-39.356401,"twenty":-11.036489,"median":-4.027189,"eighty":-2.290222,"marketCap":18812359714},{"date":"2024-06-14","current":-41.228259,"twenty":-11.179023,"median":-4.073267,"eighty":-2.289098,"marketCap":19707107707},{"date":"2024-06-21","current":-40.422649,"twenty":-11.296334,"median":-4.121613,"eighty":-2.287973,"marketCap":19322026292},{"date":"2024-06-28","current":-38.527097,"twenty":-11.385149,"median":-4.151587,"eighty":-2.285634,"marketCap":18415952375},{"date":"2024-07-05","current":-39.853984,"twenty":-11.621943,"median":-4.174737,"eighty":-2.285634,"marketCap":19050204117},{"date":"2024-07-12","current":-40.517427,"twenty":-11.801067,"median":-4.198404,"eighty":-2.285634,"marketCap":19367329988},{"date":"2024-07-15","current":-40.943926,"twenty":-11.803174,"median":-4.207927,"eighty":-2.285634,"marketCap":19571196620},{"date":"2024-08-02","current":-43.865831,"twenty":-12.11229,"median":-4.314015,"eighty":-2.263795,"marketCap":19871221474},{"date":"2024-08-09","current":-42.918652,"twenty":-12.52622,"median":-4.371837,"eighty":-2.286849,"marketCap":19442149532},{"date":"2024-08-16","current":-45.844924,"twenty":-12.72843,"median":-4.404346,"eighty":-2.300344,"marketCap":20767750637},{"date":"2024-08-23","current":-45.994989,"twenty":-13.2484,"median":-4.445318,"eighty":-2.342265,"marketCap":20835730180},{"date":"2024-08-30","current":-46.845359,"twenty":-13.425334,"median":-4.479591,"eighty":-2.416103,"marketCap":21220947595},{"date":"2024-09-06","current":-46.095033,"twenty":-13.573381,"median":-4.534771,"eighty":-2.445786,"marketCap":20881049876},{"date":"2024-09-13","current":-45.044576,"twenty":-13.790035,"median":-4.59248,"eighty":-2.462375,"marketCap":20405193069},{"date":"2024-09-20","current":-44.419305,"twenty":-13.920028,"median":-4.678715,"eighty":-2.479685,"marketCap":20121944970},{"date":"2024-09-27","current":-44.369283,"twenty":-14.16918,"median":-4.685261,"eighty":-2.507741,"marketCap":20099285122},{"date":"2024-10-04","current":-43.468892,"twenty":-14.281118,"median":-4.725391,"eighty":-2.528045,"marketCap":19691407859},{"date":"2024-10-11","current":-43.543924,"twenty":-14.56378,"median":-4.755489,"eighty":-2.551354,"marketCap":19725397631},{"date":"2024-10-18","current":-44.919522,"twenty":-14.798864,"median":-4.790604,"eighty":-2.565388,"marketCap":20348543450},{"date":"2024-10-25","current":-45.644837,"twenty":-14.9835,"median":-4.800636,"eighty":-2.581284,"marketCap":20677111245},{"date":"2024-10-31","current":-46.495207,"twenty":-15.044047,"median":-4.830735,"eighty":-2.591832,"marketCap":21062328660},{"date":"2024-11-08","current":-20.676099,"twenty":-15.165789,"median":-4.848504,"eighty":-2.610103,"marketCap":19828378745},{"date":"2024-11-15","current":-19.78998,"twenty":-15.257672,"median":-4.864345,"eighty":-2.614015,"marketCap":18978591084},{"date":"2024-11-22","current":-20.179872,"twenty":-15.324068,"median":-4.893439,"eighty":-2.614015,"marketCap":19352497655},{"date":"2024-11-29","current":-19.852409,"twenty":-15.363905,"median":-4.906541,"eighty":-2.614015,"marketCap":19038460421},{"date":"2024-12-06","current":-21.082833,"twenty":-15.616208,"median":-4.978148,"eighty":-2.614015,"marketCap":20218436514},{"date":"2024-12-13","current":-19.887902,"twenty":-15.887969,"median":-5.021355,"eighty":-2.615541,"marketCap":19072498193},{"date":"2024-12-20","current":-25.21185,"twenty":-16.001301,"median":-5.037892,"eighty":-2.615541,"marketCap":24178163980},{"date":"2024-12-27","current":-26.76171,"twenty":-16.173929,"median":-5.056349,"eighty":-2.615541,"marketCap":25664480020},{"date":"2025-01-03","current":-25.200019,"twenty":-16.249059,"median":-5.107143,"eighty":-2.617065,"marketCap":24166818056},{"date":"2025-01-10","current":-25.424808,"twenty":-16.357877,"median":-5.126699,"eighty":-2.628591,"marketCap":24382390611},{"date":"2025-01-17","current":-25.649597,"twenty":-16.471424,"median":-5.161813,"eighty":-2.638802,"marketCap":24597963166},{"date":"2025-01-24","current":-25.779738,"twenty":-16.785953,"median":-5.191279,"eighty":-2.638802,"marketCap":24722768330},{"date":"2025-01-31","current":-12.349682,"twenty":-16.846119,"median":-5.228095,"eighty":-2.638802,"marketCap":20241128362},{"date":"2025-02-07","current":-11.960995,"twenty":-16.846119,"median":-5.277021,"eighty":-2.638802,"marketCap":19604070932},{"date":"2025-02-14","current":-11.504416,"twenty":-16.846119,"median":-5.287221,"eighty":-2.638802,"marketCap":18855737398},{"date":"2025-02-21","current":-11.884843,"twenty":-16.846119,"median":-5.287221,"eighty":-2.638802,"marketCap":19479257713},{"date":"2025-02-28","current":-11.409449,"twenty":-16.846119,"median":-5.287221,"eighty":-2.638802,"marketCap":18700087404},{"date":"2025-03-07","current":-10.731314,"twenty":-16.84738,"median":-5.284921,"eighty":-2.637593,"marketCap":17588623876},{"date":"2025-03-14","current":-11.507324,"twenty":-16.84738,"median":-5.284921,"eighty":-2.637593,"marketCap":18860504820},{"date":"2025-03-21","current":-11.353521,"twenty":-16.84738,"median":-5.284921,"eighty":-2.637593,"marketCap":18608420309},{"date":"2025-03-28","current":-10.829189,"twenty":-16.84738,"median":-5.284921,"eighty":-2.637593,"marketCap":17749041292},{"date":"2025-04-04","current":-10.38176,"twenty":-16.84738,"median":-5.284921,"eighty":-2.637593,"marketCap":17015704531},{"date":"2025-04-11","current":-8.96257,"twenty":-16.846119,"median":-5.287221,"eighty":-2.638802,"marketCap":14689651992},{"date":"2025-04-17","current":-9.389026,"twenty":-16.846119,"median":-5.287221,"eighty":-2.638802,"marketCap":15388613593},{"date":"2025-04-25","current":-10.300945,"twenty":-16.84738,"median":-5.284921,"eighty":-2.637593,"marketCap":16883249065},{"date":"2025-05-02","current":-10.930758,"twenty":-16.84738,"median":-5.284921,"eighty":-2.637593,"marketCap":17915512935},{"date":"2025-05-09","current":-16.116302,"twenty":-16.84738,"median":-5.284921,"eighty":-2.637593,"marketCap":20725564579},{"date":"2025-05-16","current":-15.046044,"twenty":-16.84738,"median":-5.284921,"eighty":-2.637593,"marketCap":19349212753},{"date":"2025-05-23","current":-15.108476,"twenty":-16.84738,"median":-5.284921,"eighty":-2.637593,"marketCap":19429499943},{"date":"2025-05-30","current":-15.634686,"twenty":-16.804259,"median":-5.284921,"eighty":-2.637593,"marketCap":20106206258},{"date":"2025-06-06","current":-15.384959,"twenty":-16.419614,"median":-5.284921,"eighty":-2.637593,"marketCap":19785057498}],"updateTime":1749536270253}}}